Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia.

ABSTRACT:

Background

Iron deficiency anaemia (IDA) is a major health issues and common type of nutritional deficiency worldwide. For IDA treatment, intravenous (IV) iron is a useful therapy.

Objective

To determine the efficacy and cost-effectiveness (CE) of intravenous (IV) Ferric Carboxymaltose (FCM) versus IV Iron Sucrose (IS) in treating IDA.

Data sources

Electronic medical record i.e. Cerner® system.

Target population

Adults patients with iron deficiency anaemia.

Time horizon

A 12-month period (01/01/2018-31/12/2018).

Perspective

Hamad Medical Corporation (HMC, a public hospital).

Intervention

IV Ferric Carboxymaltose versus IV Iron Sucrose.

Outcome measures

With regard to responses to treatment i.e., efficacy of treatment with FCM & IS in

SUBMITTER: Basha A 

PROVIDER: S-EPMC8354439 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature